首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor? (letter; comment) (see comments)

【24h】

Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor? (letter; comment) (see comments)

机译：VIII因子产物的变化是否是形成VIII因子抑制剂的危险因素？（字母;评论）（请参阅评论）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis》 |1998年第6期|共2页
作者
Baglin T; Beacham E;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;神经病学;
关键词
Factor VIII; Hemophilia A; Isoantibodies; 因子Ⅷ; 血友病; A型; 同种抗体;

机译：Factor VIII;Hemophilia A;Isoantibodies;因子Ⅷ;血友病;A型;同种抗体;

相似文献

外文文献
中文文献
专利

1. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor? (letter; comment) (see comments) [J] . Baglin T, Beacham E Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 1998,第6期

机译：VIII因子产物的变化是否是形成VIII因子抑制剂的危险因素？（字母;评论）（请参阅评论）
2. Prediction of factor VIII VIII inhibitor development in the SIPPET SIPPET cohort by mutational analysis and factor VIII VIII antigen measurement [J] . Spena S., Garagiola I., Cannavò A., Journal of thrombosis and haemostasis: JTH . 2018,第4期

机译：通过突变分析和因子VIII抗原测量预测Sippet Sippet队列中的因子VIII VIII抑制剂发育
3. Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A [J] . MancusoM.E., MannucciP.M., RocinoA., Journal of thrombosis and haemostasis: JTH . 2012,第5期

机译：VIII因子产物的来源和纯度是A型血友病患者抑制剂形成的危险因素
4. Snactlwation of Animal Factor VIII by human Factor fill Inhibitors: Special Methodological Features in Performing the Factor VIII Assay and the Bethesda Assay [C] . G. Lutze (Jr.), V. Aumann, G. Lutze (Sen.), Hemophilie-Symposion . 2003

机译：人体因子填充抑制剂的动物因子VIII的脱裂化：在进行因子VIII测定中的特殊方法论特征及百乙醚测定
5. Characterization of VLDL receptor interactions with plasma proteins lipoprotein(a), apolipoprotein E, tissue factor pathway inhibitor, and factor VIII [D] . Ruiz, Jose Fernando 2004

机译：VLDL受体与血浆蛋白脂蛋白（a），载脂蛋白E，组织因子途径抑制剂和因子VIII相互作用的表征
6. Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody both of which inhibit factor VIII procoagulant activity to amino acid residues threonine351-serine365 of the factor VIII heavy chain. [O] . P A Foster, C A Fulcher, R A Houghten, 1988

机译：将均抑制因子VIII促凝活性的鼠单克隆抗因子VIII抗体和人抗因子VIII同种抗体的结合区定位于因子VIII重链的苏氨酸351-丝氨酸365的氨基酸残基。
7. Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A [O] . M. E. MANCUSO, P. M. MANNUCCI, A. ROCINO, 2012

机译：因子VIII产品的来源和纯度作为血友病患者抑制剂发育的危险因素
8. Cooperative Study of Spontaneously-Occurring Factor VIII Inhibitors in Patients with Hemophilia A [R] . Shapiro, S. S. 1981

机译：血友病a患者自发性因子VIII抑制剂的合作研究

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号